Project Number 1R43AG077967-01A1 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for Extended-Release Formulation of Mas Receptor Agonists as Novel Therapeutics for Treating Cognitive Impairment in Patients at-risk forAlzheimer's Disease-Related Dementias and Vascular Dementia Research Categorization Primary Disease / Condition Vascular Dementia/Dysfunction CADRO Category C. Translational Research and Clinical Interventions 4. Non-clinical Drug Development (small molecules and biologics) k. Vasculature Researcher and Organization Principal Investigator OSSANNA, NINA Principal Investigator First Name NINA Principal Investigator Last Name OSSANNA Awardee Organization PRONEUROGEN, INC. Awardee State Arizona Contact PI Country United States Project Detail Funding Opportunity Announcement PAS-19-316: Advancing Research on Alzheimer's Disease (AD) and Alzheimer's-Disease-Related Dementias (ADRD) (R43/R44 Clinical Trial Optional) FY Overall Cost $499,763 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official MARTIN, ZANE
